|
|
| MRD / Regn No. |
: 20260000315 |
Date |
: 29/06/2026 |
| Patient Name |
: Punam Saha |
Age & Gender |
: 36 Yrs. / Female |
| Contact No. |
: 9831731751 |
UHID |
: |
| Ht / Wt / BMI |
: 161 / 78 / 30.09 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (15/Apr/2026) | OBESITY (15/Apr/2026) | OBESITY WITH METABOLIC COMPLICATIONS (15/Apr/2026) | VITAMIN D DEFICIENCY (15/Apr/2026) | |
|
Subjective |
: |
HX OF GDM,POST GDM RECURRENCE OF DM,DYSESTHESIAS,HAS STOPPED MEDICATIONS |
|
Objective |
: |
NONE |
|
Analysis |
: |
OBESITY,TYPE 2 DM,VITAMIN D DEFICIENCY |
|
Plan |
: |
RESTART MOUNJARO,SEE ME IN 1 MONTH |
|
| Salient Investigations |
: |
GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.9 % | HEMOGLOBIN: 11.7 g/dL | MCH: 23.8 pg | MCHC: 29.0 gm % | MCV: 82.3 fl | PCV: 40.4 % | PLATELETS: 153 thou cells/ ul | RBC COUNT: 4.91 million/ul | TOTAL COUNT WBC: 8120 Cells/cmm | FASTING PLASMA GLUCOSE (FPG): 169.76 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 320.25 mg/dL | A\G RATIO: 2 g/dl | ALBUMIN (SERUM): 4.59 g/dL | ALKALINE PHOSPHOTASE: 62.64 IU/L | DIRECT BILIRUBIN: 0.12 mg/dl | GAMMA GLUTAMYL TRANSFERASE (GGT): 27.61 U/L | GLOBULIN: 3.00 g/dl | INDIRECT BILIRUBIN: 0.32 | SGOT (AST): 24 U/L | SGPT (ALT): 22 IU/L | TOTAL BILIRUBIN: 0.44 mg/dL | TOTAL PROTEIN: 7.59 g/dl | CREATININE: 0.72 mg/dL | BUN BLOOD UREA NITROGEN: 10.90 mg/dL | URIC ACID: 6.92 | CALCIUM: 9.30 mg/DL | ESR: 12 mm/hour | VITAMIN D (25 OH): 56 ng/mL | POTASSIUM: 4.30 meQ/L | SODIUM: 139 meq/L | HDL HIGH DENSITY LIPOPROTEIN: 36 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 126 mg/dL | TGL TRIGLYCERIDE: 293 mg/dL | TOTAL CHO/HDL RATIO: 6.06 | TOTAL CHOLESTEROL: 221 mg/dl | VLDL: 58 mg/dl | FREE T3: 2.45 ng/dL | FREE T4 : 1.21 ng/dL | TSH : 1.99 mIU/L | FIB4: 1.20 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | FIB4: 1.20 | FIB4: 1.20 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | EGFR EGLOMERULAR FILTRATION RATE: 98.07 mL/min/1.73m2 | FREE T3: 2.45 ng/dL | FREE T4 : 1.21 ng/dL | TSH : 1.99 mIU/L | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION TIRZEPATIDE 2.5 MG
MOUNJARO
Medicine For DIABETES OBESITY |
SQ |
ONCE A WEEK |
AS DIRECTED
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA AND VISUAL DISTURBANCES | |
|
2 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH TIRZEPATIDE HAVE BEEN REPORTED |
| Next Visit |
: 29/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP |
| |
|
| |
|
